Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
Authors
Keywords
Vorinostat, Cholangiocarcinoma, Nanoparticles, Poly(<span class=EmphasisTypeSmallCaps >dl, Block copolymer, Cancer chemotherapy, Drug targeting
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-26
DOI
10.1186/s12951-015-0122-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors
- (2015) Edina C. Wang et al. BIOMATERIALS
- Systemic and Targeted Therapy for Biliary Tract Tumors and Primary Liver Tumors
- (2014) Melanie Byrne Thomas Surgical Oncology Clinics of North America
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex
- (2012) Ji-young Kim et al. BIOMATERIALS
- Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial
- (2012) Toshihiko Doi et al. International Journal of Clinical Oncology
- Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)‐b‐poly(dl‐lactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine
- (2012) Elham A. Mohamed et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- SAHA Inhibits the Growth of Colon Tumors by Decreasing Histone Deacetylase and the Expression of Cyclin D1 and Survivin
- (2012) Jong-Shiaw Jin et al. PATHOLOGY & ONCOLOGY RESEARCH
- Biodegradable Thermosensitive Hydrogel for SAHA and DDP Delivery: Therapeutic Effects on Oral Squamous Cell Carcinoma Xenografts
- (2012) Jing Li et al. PLoS One
- Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis: Figure 1
- (2011) Wei-Jian Sun et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer
- (2011) J. R. A. Skipworth et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher
- (2011) Wooram Park et al. BIOMATERIALS
- Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo
- (2011) B. Ramaswamy et al. BREAST CANCER RESEARCH AND TREATMENT
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells
- (2011) Kyu-Don Chung et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma
- (2011) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma
- (2011) Sirintip Boonjaraspinyo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer
- (2011) Sofie Claerhout et al. PLoS One
- Polylactide (PLA)-based amphiphilic block copolymers: synthesis, self-assembly, and biomedical applications
- (2011) Jung Kwon Oh Soft Matter
- Role of histone deacetylase expression in intrahepatic cholangiocarcinoma
- (2011) Yuji Morine et al. SURGERY
- Targeted Therapy for Biliary Tract Cancer
- (2011) Junji Furuse et al. Cancers
- Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
- (2010) Yuan-Ling Liu et al. Autophagy
- Hybrid liposomes inhibit the growth of Cholangiocarcinoma by induction of cell cycle arrest in G1 phase
- (2010) Tomomi Towata et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
- (2010) E Di Gennaro et al. BRITISH JOURNAL OF CANCER
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiotherapy and Chemotherapy as Therapeutic Strategies in Extrahepatic Biliary Duct Carcinoma
- (2010) Thomas B. Brunner et al. STRAHLENTHERAPIE UND ONKOLOGIE
- HDAC expression and clinical prognosis in human malignancies
- (2008) Wilko Weichert CANCER LETTERS
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
- Area of paradoxical signal drop after the administration of superparamagnetic iron oxide on the T2-weighted image of a patient with lymphangitic metastasis of the liver
- (2008) Youkyung Lee et al. MAGNETIC RESONANCE IMAGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now